TRACEY CLONINGER: Open Payments
NPI 1164592275 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,891 in 132 payments from 18 companies in 2025. Trend: 2023 $3,216 · 2024 $2,871 · 2025 $2,891
Food & beverage: $2,791Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $547 |
| ABBVIE INC. | 25 | $524 |
| Novartis Pharmaceuticals Corporation | 19 | $313 |
| Janssen Biotech, Inc. | 15 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $211 |
| Incyte Corporation | 7 | $184 |
| Lilly USA, LLC | 13 | $172 |
| Regeneron Healthcare Solutions, Inc. | 5 | $132 |
| Amgen Inc. | 4 | $118 |
| LEO Pharma Inc. | 5 | $108 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, OPZELURA, ILUMYA, OTEZLA, EBGLYSS.
Industry payments across NC — which companies pay providers there.
